Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
Citation:
|
Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
|
Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
Citation:
|
Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
|